Folks, If I were to tell you of a stock that has ~2.6M o/s,
Folks, If I were to tell you of a stock that has ~2.6M o/s, with a Market Cap of HALF of 2018 Annual Sales, and Revenue of $24+M and growing - would you be interested ?
Well, INNVD (LOW FLOATER) is exactly that. Even with a little dilution, you will have maybe 4M o/s on the books and at just 1.5x Sales, Market Cap should be approaching $36M. That would reflect a FMV of closer to $9PPS. Well, it's trading at $5.50 folks...easy 50%+ gainer here IMO. GLTY INNVD (yes, it just split - low floater)
* They also recently launched a CBD sleep aid and the Cannabis crowd hasn't jumped in yet. May want to check it out
1
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Papa John’s $2.7 Billion Takeover Bid: Insights into Potential Value Recently, shares of Papa John’s International Inc (NASDAQ:PZZA) experienced a notable surge, leading to a halt in trading due to high volatility. This surprising movement came in light of credible reports suggesting a take-private cash offer of $65 per share from TriArtisan Capital Advisors, totaling...
Continue Reading
Octopus Apollo VCT plc AGM Results Overview Octopus Apollo VCT plc recently conducted its Annual General Meeting (AGM), showcasing significant engagement from shareholders. The meeting aimed to discuss key resolutions impacting the future direction of the company. Voting Outcomes of the AGM The company disclosed that all resolutions were successfully passed during the...
Continue Reading
Carisma Therapeutics Showcases Strong Financial Performance Carisma Therapeutics Inc. (NASDAQ: CARM), a clinical-stage biopharmaceutical company, recently released its financial performance for the third quarter of 2024. With a focus on developing innovative immunotherapies, Carisma provided insight into its ongoing projects. Key Developments and Milestones Carisma's...
Continue Reading
Overview of the Epinephrine Market The global epinephrine market is on a significant upswing, with recent evaluations estimating its value at USD 3.11 billion and a projected growth to approximately USD 6.39 billion within the next decade. As a critical hormone and neurotransmitter produced by the adrenal glands, epinephrine is essential in treating severe allergic...
Continue Reading
Canadian North Resources Makes Significant Progress in Operational Strategy Highlights: Canadian North has expanded its bio-metallurgical programs significantly, achieving impressive nickel and cobalt extraction rates through innovative bio-leaching tests. The focus remains on extracting copper and other precious group elements (PGE) metals from the Ferguson Lake Project....
Continue Reading
